Radiation Therapy
SABR for Prostate Cancer
Sunnybrook Health Sciences Centre, Toronto, Canada
SABRN/AWaitlist AvailableLed by Andrew Loblaw, MD, FRCPCResearch Sponsored by Sunnybrook Health Sciences CentreEligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Must not have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up5 year
Awards & highlights
No Placebo-Only Group
Study Summary
This trial will study the prostate-specific quality of life of patients undergoing a two-fraction MRI-guided stereotactic ablative body radiation protocol.
Eligible Conditions
- Prostate Cancer
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 5 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
QOL
Secondary outcome measures
Acute Toxicity
Biochemical Recurrance
Health Utilities
+3 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: 2-fraction SABRExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
SABR
2013
Completed Phase 2
~70
Find a site
Who is running the clinical trial?
Sunnybrook Health Sciences CentreLead Sponsor
633 Previous Clinical Trials
1,478,307 Total Patients Enrolled
32 Trials studying Prostate Cancer
12,152 Patients Enrolled for Prostate Cancer
Andrew Loblaw, MD, FRCPCPrincipal Investigator
Sunnybrook Health Sciences Centre, University of Toronto1 Previous Clinical Trials
30 Total Patients Enrolled
1 Trials studying Prostate Cancer
30 Patients Enrolled for Prostate Cancer
Media Library
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are researchers currently recruiting participants for this investigation?
"The information found on clinicaltrials.gov confirms that this medical study, posted April 23rd 2018 and last edited June 12th 2022 is not accepting patient applications at present. However, an impressive 1321 other trials are presently recruiting participants across the globe."
Answered by AI